Cargando…

HTLV-1 Infection and Rheumatic Diseases

Some major research and clinical questions about human T-cell leukemia virus type 1 (HTLV-1) infection and rheumatic diseases remain: (1) Does HTLV-1 infection cause rheumatic diseases? (2) Do patients with rheumatic diseases display different responses to treatment with anti-rheumatic agents when t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Umekita, Kunihiko, Okayama, Akihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025999/ https://www.ncbi.nlm.nih.gov/pubmed/32117170 http://dx.doi.org/10.3389/fmicb.2020.00152

Ejemplares similares

Effect of HTLV-1 Infection on the Clinical Course of Patients with Rheumatoid Arthritis
por: Umekita, Kunihiko
Publicado: (2022)

Adult T-cell Leukemia/Lymphoma as a Methotrexate-associated Lymphoproliferative Disorder in a Patient with Rheumatoid Arthritis
por: Takajo, Ichiro, et al.
Publicado: (2018)

HTLV-1 HBZ Viral Protein: A Key Player in HTLV-1 Mediated Diseases
por: Baratella, Marco, et al.
Publicado: (2017)

Fine tuning of the temporal expression of HTLV-1 and HTLV-2
por: Cavallari, Ilaria, et al.
Publicado: (2013)

HTLV-1 in Ophthalmology
por: Kamoi, Koju
Publicado: (2020)

HTLV-1 uveitis
por: Kamoi, Koju, et al.
Publicado: (2012)

Epidemiology of HTLV-1 Infection and ATL in Japan: An Update
por: Iwanaga, Masako
Publicado: (2020)

Novel perspectives on antisense transcription in HIV-1, HTLV-1, and HTLV-2
por: Lin, Edward, et al.
Publicado: (2022)

Epidemiological Aspects and World Distribution of HTLV-1 Infection
por: Gessain, Antoine, et al.
Publicado: (2012)

EZH1/2 dual inhibitors suppress HTLV-1-infected cell proliferation and hyperimmune response in HTLV-1-associated myelopathy
por: Koseki, Akihito, et al.
Publicado: (2023)

Functional comparison of antisense proteins of HTLV-1 and HTLV-2 in viral pathogenesis
por: Barbeau, Benoit, et al.
Publicado: (2013)

The Exceptional Oncogenicity of HTLV-1
por: Tagaya, Yutaka, et al.
Publicado: (2017)

Editorial to the Research Topic “Comparative studies between HTLV-1 and HTLV-2 function and pathobiology”
por: Bertazzoni, Umberto
Publicado: (2015)

The Role of Chemokines in the Pathogenesis of HTLV-1
por: Zargari, Razieh, et al.
Publicado: (2020)

Forefront studies on HTLV-1 oncogenesis
por: Mahieux, Renaud, et al.
Publicado: (2013)

Editorial: Molecular Pathology of HTLV-1
por: Bertazzoni, Umberto, et al.
Publicado: (2018)

Impact of C-Reactive Protein Levels on Differentiating of Severe Fever With Thrombocytopenia Syndrome From Japanese Spotted Fever
por: Kawaguchi, Takeshi, et al.
Publicado: (2020)

Corticosteroids May Have Negative Effects on the Management of Patients with Severe Fever with Thrombocytopenia Syndrome: A Case–Control Study
por: Kawaguchi, Takeshi, et al.
Publicado: (2021)

A newly identified interaction between nucleolar NPM1/B23 and the HTLV-I basic leucine zipper factor in HTLV-1 infected cells
por: Liu, Zhenlong, et al.
Publicado: (2022)

Updates on HTLV-1 Uveitis
por: Kamoi, Koju, et al.
Publicado: (2022)

HBZ and its roles in HTLV-1 oncogenesis
por: Zhao, Tiejun, et al.
Publicado: (2012)

Pathways of cell-cell transmission of HTLV-1
por: Pique, Claudine, et al.
Publicado: (2012)

How to Control HTLV-1-Associated Diseases: Preventing de Novo Cellular Infection Using Antiviral Therapy
por: Pasquier, Amandine, et al.
Publicado: (2018)

HTLV-1/-2 and HIV-1 co-infections: retroviral interference on host immune status
por: Pilotti, Elisabetta, et al.
Publicado: (2013)

A Strategy for Screening and Confirmation of HTLV-1/2 Infections in Low-Endemic Areas
por: Ji, Huimin, et al.
Publicado: (2020)

Cellular Factors Involved in HTLV-1 Entry and Pathogenicit
por: Hoshino, Hiroo
Publicado: (2012)

HTLV-1 Alters T Cells for Viral Persistence and Transmission
por: Tanaka, Azusa, et al.
Publicado: (2018)

Mechanism of Secondary Glaucoma Development in HTLV-1 Uveitis
por: Zong, Yuan, et al.
Publicado: (2022)

Increased Prevalence of HTLV‐I Infection in Patients with Hepatocellular Carcinoma Associated with Hepatitis C Virus
por: Okayama, Akihiko, et al.
Publicado: (1995)

Inhibition of HTLV-1 Infection by HIV-1 First- and Second-Generation Integrase Strand Transfer Inhibitors
por: Barski, Michał S., et al.
Publicado: (2019)

The need to accessorize: molecular roles of HTLV-1 p30 and HTLV-2 p28 accessory proteins in the viral life cycle
por: Anupam, Rajaneesh, et al.
Publicado: (2013)

HTLV-1: Regulating the Balance Between Proviral Latency and Reactivation
por: Kulkarni, Anurag, et al.
Publicado: (2018)

Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM/TSP
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2017)

Mother-to-Child HTLV-1 Transmission: Unmet Research Needs
por: Rosadas, Carolina, et al.
Publicado: (2019)

Association Between HTLV-1 Genotypes and Risk of HAM/TSP
por: Saito, Mineki
Publicado: (2019)

HTLV-1 Extracellular Vesicles Promote Cell-to-Cell Contact
por: Pinto, Daniel O., et al.
Publicado: (2019)

In vitro Evaluation of the Safety of Adalimumab for the Eye Under HTLV-1 Infection Status: A Preliminary Study
por: Kurozumi-Karube, Hisako, et al.
Publicado: (2020)

Proposal of Classification Criteria for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Disease Activity
por: Sato, Tomoo, et al.
Publicado: (2018)

Tumor necrosis factor alpha inhibitors have no effect on a human T-lymphotropic virus type-I (HTLV-I)-infected cell line from patients with HTLV-I-associated myelopathy
por: Fukui, Shoichi, et al.
Publicado: (2017)

Family Aggregation of HTLV-1 Infection Associated with FAS -670A/G Polymorphism: A Case Report
por: Vallinoto, Antonio C. R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tf4nntgrkto9sf5qdbdnlmkmbj